IVZ stock · THAR stock

IVZ vs THAR · rev $3.57B vs $187.4M cap

Invesco Plc (IVZ) versus Tharimmune Inc. (THAR) — a side-by-side from cached financials, not a winner call.

Invesco Plc (IVZ) is a asset management company listed on NYSE.

Tharimmune Inc. (THAR) is a biotechnology company listed on NASDAQ.

Latest reported IVZ revenue for 2026-06-30 was $3.57B. Net income was $558.0M. IVZ currently screens at market cap $12.76B.

THAR does not have a complete income-statement cache yet.

IVZ currently screens at market cap $12.76B. THAR currently screens at market cap $187.4M.

Not investment advice. Open the IVZ and THAR stock pages for the full models.

Not investment advice.

Popular Stock Comparisons